BioLife Solutions, Inc. Deferred Tax Assets, Operating Loss Carryforwards
BioLife Solutions, Inc. (BLFS) had Deferred Tax Assets, Operating Loss Carryforwards of $37.44 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $37.44M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $39.08M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $35.51M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.10M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $37.44M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $39.08M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $35.51M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $29.10M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $27.50M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $12.31M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $9.49M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $7.38M 10-K · filed 2020-05-15 | |
| 2017-12-31 | $8.16M 10-K · filed 2019-03-15 | $8.16M 10-K · filed 2018-03-09 |
| 2016-12-31 | $11.96M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $11.08M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $10.05M 10-K · filed 2016-02-25 | $10.05M 10-K · filed 2015-03-12 |
| 2013-12-31 | $7.84M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $7.82M 10-K · filed 2014-02-12 | |
| 2011-12-31 | $8.21M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |